STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has entered into an agreement with Uluru Inc, a US specialty pharma company, for Amlexanox 5% paste and OraDisc A™. The agreement gives Meda exclusive rights to the products in most European countries, including Eastern Europe.
